Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia

Primary immune thrombocytopenia (ITP) is an acquired autoimmune bleeding disorder, characterized by a low platelet count (

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of hematology 2020-02, Vol.95 (2), p.178-187
Hauptverfasser:	Newland, Adrian C., Sánchez‐González, Blanca, Rejtő, László, Egyed, Miklos, Romanyuk, Nataliya, Godar, Marie, Verschueren, Katrien, Gandini, Domenica, Ulrichts, Peter, Beauchamp, Jon, Dreier, Torsten, Ward, E. Sally, Michel, Marc, Liebman, Howard A., Haard, Hans, Leupin, Nicolas, Kuter, David J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Autoantibodies Bleeding Double-Blind Method Fc receptors Female Follow-Up Studies Hematology Histocompatibility Antigens Class I - blood Humans Idiopathic thrombocytopenic purpura Immune clearance Immunoglobulin Fc Fragments - therapeutic use Immunoglobulin G Immunoglobulin G - therapeutic use Intravenous administration Male Middle Aged Neonates Platelet Count Platelets Purpura, Thrombocytopenic, Idiopathic - blood Purpura, Thrombocytopenic, Idiopathic - drug therapy Quality of life Receptors, Fc - antagonists & inhibitors Receptors, Fc - blood Thrombocytopenia
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Primary immune thrombocytopenia (ITP) is an acquired autoimmune bleeding disorder, characterized by a low platelet count (
ISSN:	0361-8609 1096-8652 1096-8652
DOI:	10.1002/ajh.25680